Related Experiment Videos
Gene therapy of gynaecological diseases
Anna Kanerva1, Mari Raki, Akseli Hemminki
1University of Helsinki, Cancer Gene Therapy Group, Transplantation Laboratory and Haartman Institute, P.O. Box 63 (Haartmaninkatu 8, 00290 Helsinki), Biomedicum, Helsinki 00014, Finland.
Abstract:
Gene therapy represents a potentially useful approach for the treatment of diseases refractory to conventional therapies. Various preclinical and clinical strategies have been explored for treatment of gynaecological diseases. Given the most severe unmet clinical need, much of the work has been performed with gynaecological cancers and ovarian cancer in particular. Although the safety of many treatment strategies has been demonstrated in early phase clinical trials, efficacy has been mostly limited heretofore. Major challenges include improving the vectors used with the aim of more effective and selective delivery. In addition, effective penetration into and spreading within advanced and complex tumour masses and metastases remains challenging. This review focuses on existing and developmental gene transfer applications for gynaecological diseases.
Insights
Gene therapy shows promise for gynecological diseases, particularly cancers. Current gene transfer strategies face challenges in effective delivery and tumor penetration, limiting efficacy.
Area of Science:
- Oncology
- Genetics
- Gynecology
Background:
- Gene therapy offers a novel treatment avenue for diseases resistant to conventional therapies.
- Significant research has focused on gynecological cancers, especially ovarian cancer, due to high unmet clinical needs.
- While early trials demonstrate safety, the efficacy of current gene therapy strategies remains limited.
Purpose of the Study:
- To review existing gene transfer applications for gynecological diseases.
- To discuss developmental strategies aimed at improving gene therapy efficacy.
- To highlight challenges in vector delivery and tumor penetration for gynecological conditions.
Main Methods:
- Literature review of preclinical and clinical studies on gene therapy for gynecological diseases.
- Analysis of gene transfer vectors and delivery systems.
- Examination of challenges in tumor penetration and spread.
Main Results:
- Gene therapy has shown safety in early clinical trials for gynecological conditions.
- Limited efficacy has been observed due to challenges in vector delivery and tumor penetration.
- Ongoing research focuses on enhancing vector effectiveness and targeting complex tumor masses.
Conclusions:
- Gene therapy holds potential for treating gynecological diseases, but efficacy needs improvement.
- Overcoming challenges in targeted delivery and tumor penetration is crucial for clinical success.
- Further development of gene transfer applications is essential for advancing gynecological cancer treatment.
Related Concept Videos
Disorders of the Female Reproductive System
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of endometrial...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Group Therapy
Sexually Transmitted Infections